Biomarker Discovery
Signals are useful only when they reproduce.
Cedarwell identifies and evaluates molecular features that may help characterize disease biology, patient subgroups, treatment response, or longitudinal change.
View frameworkEVIDENCE MAP / CLOUD
01COHORTMEASURE
02ASSAYVALIDATE
03SIGNALMEASURE
04REPLICATIONVALIDATE
05CONTEXTMEASURE
CEDARWELL BIOSCIENCESDESIGN · MEASURE · ANALYZE · TRANSLATE
Capability overview
Methods follow
the scientific question.
Discovery work is designed to separate interesting signals from durable evidence. Programs emphasize cohort definition, specimen quality, multiplicity, replication, biological context, and clear criteria for advancing candidates.
Program focus
What the work
needs to control.
Specimen QC
Feature generation
Signal discovery
Multiplicity control
Biological annotation
Replication
Subgroup analysis
Candidate ranking
Evidence review
Workflow
Defined steps.
Reviewable decisions.
Define
Specify the population, endpoint, confounders, and advancement criteria.
Discover
Generate and analyze molecular features while preserving sample and analytical provenance.
Replicate
Test candidate signals in independent data or specimens where appropriate.
Prioritize
Integrate statistical strength, biological plausibility, assay feasibility, and intended use.
Connected science
One evidence chain,
not isolated functions.
Candidate biomarkers can move into Cedarwell assay-development and translational workflows for deeper characterization and fit-for-purpose validation.
Research collaborations
Have a molecular question worth testing?
Contact Cedarwell Biosciences to discuss a focused research, diagnostic-development, or translational program.
Contact our team